NEW YORK, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
- BioHaven Pharmaceutical Holding Company Ltd. (BHVN), relating to its proposed merger with Pfizer Inc. Under the terms of the agreement, BHVN shareholders will receive 0.5 shares of New Biohaven and $148.50 in cash per share. Click here for more information: http://monteverdelaw.com/case/biohaven-pharmaceutical-holding-company-ltd. It is free and there is no cost or obligation to you.
- 1Life Healthcare, d.b.a One Medical (ONEM), relating to its proposed acquisition by Amazon.com, Inc. Under the terms of the agreement, ONEM shareholders will receive $18.00 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/1life-healthcare-inc. It is free and there is no cost or obligation to you.
- Global Blood Therapeutics, Inc. (GBT), relating to its proposed acquisition by Pfizer Inc. Under the terms of the agreement, GBT shareholders are expected to receive $68.50 in cash per share they own. Click here for more information: https://www.monteverdelaw.com/case/global-blood-therapeutics-inc. It is free and there is no cost or obligation to you.
- Centennial Resource Development, Inc. (CDEV), relating to its proposed merger with Colgate Energy Partners III, LLC. Under the terms of the agreement, CDEV shareholders will own approximately 53% of the combined company. Click here for more information: https://www.monteverdelaw.com/case/centennial-resource-development-inc. It is free and there is no cost or obligation to you.
About Monteverde & Associates PC
We are a national class action securities litigation law firm that has recovered millions of dollars and is committed to protecting shareholders from corporate wrongdoing. We were listed in the Top 50 in the 2018-2021 ISS Securities Class Action Services Report. Our lawyers have significant experience litigating Mergers & Acquisitions and Securities Class Actions. Mr. Monteverde is recognized by Super Lawyers as a Rising Star in Securities Litigation in 2013, 2017-2019, an award given to less than 2.5% of attorneys in a particular field. He has also been selected by Martindale-Hubbell as a 2017-2021 Top Rated Lawyer. Our firm's recent successes include changing the law in a significant victory that lowered the standard of liability under Section 14(e) of the Exchange Act in the Ninth Circuit. Thereafter, our firm successfully preserved this victory by obtaining dismissal of a writ of certiorari as improvidently granted at the United States Supreme Court. Emulex Corp. v. Varjabedian, 139 S. Ct. 1407 (2019). Also, in 2019 we recovered or secured six cash common funds for shareholders in mergers & acquisitions class action cases.
If you own common stock in any of the above listed companies and wish to obtain additional information and protect your investments free of charge, please visit our website or contact Juan E. Monteverde, Esq. either via e-mail at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.
Contact:
Juan E. Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4405
New York, NY 10118
United States of America
jmonteverde@monteverdelaw.com
Tel: (212) 971-1341
Attorney Advertising. (C) 2022 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.
![](https://ml.globenewswire.com/media/NjlhODJlZmItMmRmOS00NGNkLTlmMTktZjJhMjkzZTFiMmRhLTExOTU5MTM=/tiny/Monteverde-Associates-PC.png)